Shunichiro Hachiya

This inventor holds 9 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 3 EPO patents. Top assignees: Astellas Pharma Gmbh, Yamanouchi Pharmaceutical Company Ltd.. Active years: 2003-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shunichiro Hachiya. Retrieved from https://idiyas.com/inventor/shunichiro-hachiya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 1)

% Patents Active = 33.3

CIPO Patents = 3

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 9.8

ph-index = 4

Forward Citations = 35(Granted Patents)

Location History:

Tsukuba, JP (2003 - 2012)
Tokyo, JP (2009 - 2016)
Chuo-ku, JP (2014 - 2016)

Company Filing History:

Yamanouchi Pharmaceutical Company Ltd.

patents

Years Active: 2003-2016

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9284295 - Tetrahydrobenzothiophene compound (2016-03-15),

2. 9278968 - Imidazopyridine compounds (2016-03-08),

3. 9062032 - Aminoalkyl-substituted N-thienylbenzamide derivative (2015-06-23),

4. 8729068 - Tetrahydrobenzothiophene compound (2014-05-20),

5. RE43481 - Diazepan derivatives or salts thereof (2012-06-18),

6. 8153658 - Piperidine derivative or salt thereof (2012-04-10),

7. 7585886 - Pyrrolidine derivative or salt thereof (2009-09-08),

8. 7307074 - Diazepan derivatives or salts thereof (2007-12-11),

9. 6642224 - Diazepan derivatives or salts thereof (2003-11-04),

Title: Shunichiro Hachiya: Innovator in Pharmaceutical Compounds

Introduction

Shunichiro Hachiya is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of nine patents. His work focuses on developing compounds that address critical health issues, particularly in the realm of cardiovascular diseases and metabolic disorders.

Latest Patents

Hachiya's latest patents include a tetrahydrobenzothiophene compound designed to inhibit the intestinal phosphate transporter (NPT-IIb). This compound serves as an active ingredient for treating and preventing hyperphosphatemia. Another notable patent involves imidazopyridine compounds, which are aimed at treating various cardiovascular diseases by enhancing sGC activities and improving cGMP signals. These compounds are particularly useful for conditions such as peripheral arterial diseases, intermittent claudication, critical limb ischemia, hypertension, and pulmonary hypertension.

Career Highlights

Throughout his career, Hachiya has worked with notable companies in the pharmaceutical industry, including Astellas Pharma GmbH and Yamanouchi Pharmaceutical Company Ltd. His innovative work has positioned him as a key figure in the development of new therapeutic agents.

Collaborations

Hachiya has collaborated with esteemed colleagues, including Yoh Terada and Yuji Koga. These partnerships have further enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Shunichiro Hachiya's contributions to pharmaceutical innovations demonstrate his commitment to improving health outcomes through scientific research. His patents reflect a deep understanding of complex medical challenges and a dedication to finding effective solutions.

Profile summary based on public USPTO records.